Activist 13D/13G Filings - PhaseBio Pharmaceuticals Inc (PHAS)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1
Reported
DateTime
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportFiling
2020-02-14
1:49 pm
Sale
13GPHASEBIO PHARMACEUTICALS INC C
PHAS
Rock Springs Capital Management LP1,125,000
3.91%
-325,000decrease
(-22.41%)
View
2020-01-27
3:36 pm
Purchase
13GPHASEBIO PHARMACEUTICALS INC C
PHAS
WELLINGTON MANAGEMENT GROUP LLP3,892,256
13.53%
521,296increase
(+15.46%)
View
2020-01-17
1:57 pm
Sale
13GPHASEBIO PHARMACEUTICALS INC C
PHAS
JOHNSON & JOHNSON
JNJ
1,607,044
5.6%
-9,819decrease
(-0.61%)
View
2019-07-29
4:27 pm
Purchase
13DPHASEBIO PHARMACEUTICALS INC C
PHAS
Hatteras Venture Advisors III LLC2,489,156
8.7%
10,692increase
(+0.43%)
View
Goto Prev, 0, 1